Today’s news
NB Bancorp CFO Increases Stake with 1,000-Share Purchase
Jean-Pierre Lapointe, the Chief Financial Officer of NB Bancorp, has acquired an additional 1,000 shares of the company's stock.

JPMorgan Chase Boosts Syndax Pharmaceuticals Price Target to $45
Wall Street firm sees 85% upside potential for biotech stock
Fieldview Capital Management Invests $5.34M in Boston Scientific
The hedge fund purchased 54,715 shares of the medical equipment provider's stock.
Recent news
Mar. 9, 2026
Vinva Investment Management Ltd Lowers Holdings in Biogen Inc.
Biotechnology firm Biogen sees institutional investor decrease stake by over 34%
Mar. 9, 2026
Russell Investments Boosts Stake in Boston Scientific
Institutional investor increases holding in medical device company by 14.7%
Mar. 9, 2026
Jefferies Financial Group Boosts Boston Scientific Holdings
Investment firm increases stake in medical device company by 17.4% in Q3
Mar. 9, 2026
Crossmark Global Holdings Inc. Increases Stake in Hologic, Inc.
The investment firm added over 16,000 shares of the medical equipment provider in the third quarter.
Mar. 9, 2026
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
Analysts raise stock rating from 'sell' to 'hold' for the biopharmaceutical company focused on rare neurological diseases.
Mar. 9, 2026
Financial Analysis: Oxford BioMedica and Immuneering
Comparing the performance and potential of two small-cap medical companies
Mar. 9, 2026
First Trust Advisors Reduces Biogen Stake by 3.8%
Institutional investor sells 33,266 shares of biotechnology company
Mar. 8, 2026
Grantham Mayo Van Otterloo & Co. LLC Reduces Stake in Ameresco, Inc.
Institutional investor trims position in renewable energy company
Mar. 8, 2026
Zenas BioPharma Receives 'Moderate Buy' Consensus Rating from Analysts
The biotech firm's stock has a 1-year average price target of $43.14 per share.
Mar. 8, 2026
Cresset Asset Management Invests $1.95M in Aardvark Therapeutics
The investment firm bought a new stake in the biotech company focused on RORγ modulators.
Mar. 8, 2026
Vinva Investment Management Boosts Boston Scientific Holdings
The institutional investor increased its stake in the medical device company by 83.2% in the third quarter.
Mar. 8, 2026
Victory Capital Management Trims Boston Scientific Stake
Institutional investor reduces holdings in medical device company by 38.7%
Mar. 8, 2026
Neuberger Berman Reduces Stake in BXP, Inc.
Asset manager lowers position in real estate investment trust by 65.8% in third quarter
Mar. 8, 2026
Orion Porfolio Solutions LLC Boosts Position in Boston Scientific Corporation
Investment firm increases stake in medical device maker by 60% in Q3
Mar. 8, 2026
Dynamic Technology Lab Invests $1.52 Million in Sensata Technologies
The investment firm purchased a new stake in the scientific and technical instruments company.
Mar. 8, 2026
Dynamic Technology Lab Invests $1.52 Million in Sensata Technologies
New 13F filing shows hedge fund purchased nearly 50,000 shares of the scientific instruments company
Mar. 8, 2026
Dynamic Technology Lab Private Ltd Buys Stake in Boston Scientific
The investment firm acquired over 24,000 shares of the medical device company in the third quarter.
Mar. 8, 2026
CM Management LLC Sells 120,000 Shares of ClearPoint Neuro, Inc.
The investment firm reduced its stake in the medical technology company by 60%.
Mar. 8, 2026
Wall Street Zen Downgrades EverQuote to 'Buy' Rating
Analysts lower price target for online insurance marketplace company
Mar. 8, 2026
Hall Capital Management Boosts Boston Scientific Holdings
Investment firm increases stake in medical device company by 298% in Q3 2025